University of Hertfordshire

From the same journal

  • Narinder Kaur-Bring
View graph of relations
Original languageEnglish
Number of pages1
Pages (from-to)S4
JournalClinical Pharmacist
Journal publication dateApr 2012
IssueS2
Publication statusPublished - Apr 2012
EventUK Clinical Pharmacy Association Autumn Symposium 2011 - , United Kingdom
Duration: 18 Nov 201121 Nov 2011

Abstract

Insulin is a high-risk drug for serious or fatal outcomes.1 The National
Patient Safety Agency recorded more than 13,000 insulin-related reports
from November 2003 to March 2009. The most common insulin errors
related to dose (strength/frequency), omission, incorrect medication and
quantity

Notes

Sanofi Aventis Diabetes Award 2011

ID: 8550690